Revealing the Molecular Mechanism of Gastric Cancer Marker Annexin A4 in Cancer Cell Proliferation Using Exon Arrays

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Lin, Li Ling ^a   Huang, Hsuan Cheng ^b   Juan, Hsueh Fen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CYCLIN DEPENDENT KINASE 1; HYALURONIC ACID; LIPOCORTIN 4; PROTEIN KINASE B; PROTEIN P21;

ARTICLE; CALCIUM SIGNALING; CANCER CELL; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; EXON; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; NONHUMAN; STOMACH CANCER; TRANSCRIPTION REGULATION;

ANNEXIN A4; CALCIUM; CELL PROLIFERATION; ENZYME ACTIVATION; EXONS; HELICOBACTER PYLORI; HUMANS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

HELICOBACTER PYLORI;

EID: 84866059921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044615     Document Type: Article

References (63)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CACancer J Clin 61: 69-90.
2. Herrera V, Parsonnet J, (2009) Helicobacter pylori and gastric adenocarcinoma. Clin Microbiol Infect 15: 971-976.
3. Kim SS, Ruiz VE, Carroll JD, Moss SF, (2011) Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. Cancer Lett 305: 228-238.
4. Kusters JG, van Vliet AH, Kuipers EJ, (2006) Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19: 449-490.
5. Fan XG, Kelleher D, Fan XJ, Xia HX, Keeling PW, (1996) Helicobacter pylori increases proliferation of gastric epithelial cells. Gut 38: 19-22.
6. Polk DB, Peek RM Jr, (2010) Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 10: 403-414.
7. Gerke V, Moss SE, (2002) Annexins: from structure to function. Physiol Rev 82: 331-371.
8. Gerke V, Creutz CE, Moss SE, (2005) Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461.
9. Monastyrskaya K, Babiychuk EB, Hostettler A, Rescher U, Draeger A, (2007) Annexins as intracellular calcium sensors. Cell Calcium 41: 207-219.
10. Fatimathas L, Moss SE, (2010) Annexins as disease modifiers. Histol Histopathol 25: 527-532.
11. Ortiz-Zapater E, Peiro S, Roda O, Corominas JM, Aguilar S, et al. (2007) Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2. Am J Pathol 170: 1573-1584.
12. Khau T, Langenbach SY, Schuliga M, Harris T, Johnstone CN, et al. (2011) Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2. FASEB J 25: 483-496.
13. Zhai H, Acharya S, Gravanis I, Mehmood S, Seidman RJ, et al. (2011) Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci 31: 14346-14360.
14. de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, et al. (2010) Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci U S A 107: 6340-6345.
15. Tanaka T, Akatsuka S, Ozeki M, Shirase T, Hiai H, et al. (2004) Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene 23: 3980-3989.
16. Dreier R, Schmid KW, Gerke V, Riehemann K, (1998) Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem Cell Biol 110: 137-148.
17. Lin LL, Chen CN, Lin WC, Lee PH, Chang KJ, et al. (2008) Annexin A4: A novel molecular marker for gastric cancer with Helicobacter pylori infection using proteomics approach. Proteomics Clin Appl 2: 619-634.
18. Lin LL, Huang HC, Juan HF, (2012) Discovery of biomarkers for gastric cancer: A proteomics approach. J Proteomics 75: 3081-3097.
19. Shen J, Person MD, Zhu J, Abbruzzese JL, Li D, (2004) Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 64: 9018-9026.
20. Miao Y, Cai B, Liu L, Yang Y, Wan X, (2009) Annexin IV is differentially expressed in clear cell carcinoma of the ovary. Int J Gynecol Cancer 19: 1545-1549.
21. Toyama A, Suzuki A, Shimada T, Aoki C, Aoki Y, et al. (2012) Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers. Cancer Sci 103: 747-755.
22. Zimmermann U, Balabanov S, Giebel J, Teller S, Junker H, et al. (2004) Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett 209: 111-118.
23. Duncan R, Carpenter B, Main LC, Telfer C, Murray GI, (2008) Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 98: 426-433.
24. Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA, (2003) Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 162: 255-261.
25. Jeon YJ, Kim DH, Jung H, Chung SJ, Chi SW, et al. (2010) Annexin A4 interacts with the NF-kappaB p50 subunit and modulates NF-kappaB transcriptional activity in a Ca2+-dependent manner. Cell Mol Life Sci 67: 2271-2281.
26. Masuda J, Takayama E, Satoh A, Ida M, Shinohara T, et al. (2004) Levels of annexin IV and V in the plasma of pregnant and postpartum women. Thromb Haemost 91: 1129-1136.
27. Kapur K, Xing Y, Ouyang Z, Wong WH, (2007) Exon arrays provide accurate assessments of gene expression. Genome Biol 8: R82.
28. Banerjee SK, Weston AP, Zoubine MN, Campbell DR, Cherian R, (2000) Expression of cdc2 and cyclin B1 in Helicobacter pylori-associated gastric MALT and MALT lymphoma: relationship to cell death, proliferation, and transformation. Am J Pathol 156: 217-225.
29. Gaudet S, Branton D, Lue RA, (2000) Characterization of PDZ-binding kinase, a mitotic kinase. Proc Natl Acad Sci U S A 97: 5167-5172.
30. Smits VA, Klompmaker R, Vallenius T, Rijksen G, Makela TP, et al. (2000) p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem 275: 30638-30643.
31. Liang J, Slingerland JM, (2003) Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2: 339-345.
32. Monteith GR, McAndrew D, Faddy HM, Roberts-Thomson SJ, (2007) Calcium and cancer: targeting Ca2+ transport. Nat Rev Cancer 7: 519-530.
33. Marlink KL, Bacon KD, Sheppard BC, Ashktorab H, Smoot DT, et al. (2003) Effects of Helicobacter pylori on intracellular Ca2+ signaling in normal human gastric mucous epithelial cells. Am J Physiol Gastrointest Liver Physiol 285: G163-176.
34. Liu C, Hermann TE, (1978) Characterization of ionomycin as a calcium ionophore. J Biol Chem 253: 5892-5894.
35. Mussunoor S, Murray GI, (2008) The role of annexins in tumour development and progression. J Pathol 216: 131-140.
36. Emoto K, Sawada H, Yamada Y, Fujimoto H, Takahama Y, et al. (2001) Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res 21: 1339-1345.
37. Li H, Guo L, Li JW, Liu N, Qi R, et al. (2000) Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression. Int J Oncol 17: 927-932.
38. Maxwell CA, McCarthy J, Turley E, (2008) Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J Cell Sci 121: 925-932.
39. Hall CL, Yang B, Yang X, Zhang S, Turley M, et al. (1995) Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell 82: 19-26.
40. Cinti C, Vindigni C, Zamparelli A, La Sala D, Epistolato MC, et al. (2008) Activated Akt as an indicator of prognosis in gastric cancer. Virchows Arch 453: 449-455.
41. Chen YR, Juan HF, Huang HC, Huang HH, Lee YJ, et al. (2006) Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. J Proteome Res 5: 2727-2742.
42. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, et al. (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 20: 1626-1638.
43. Hunter T, Pines J, (1991) Cyclins and cancer. Cell 66: 1071-1074.
44. Han EK, Tahir SK, Cherian SP, Collins N, Ng SC, (2000) Modulation of paclitaxel resistance by annexin IV in human cancer cell lines. Br J Cancer 83: 83-88.
45. Kim A, Enomoto T, Serada S, Ueda Y, Takahashi T, et al. (2009) Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin. Int J Cancer 125: 2316-2322.
46. Yamashita T, Nagano K, Kanasaki SI, Maeda Y, Furuya T, et al. (2012) Annexin A4 is a possible biomarker for cisplatin susceptibility of malignant mesothelioma cells. Biochem Biophys Res Commun 421: 140-144.
47. Ono M, Yano M, Hino A, Suetomi T, Xu X, et al. (2010) Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure. Cardiovasc Res 87: 609-617.
48. Verity MA, (1992) Ca(2+)-dependent processes as mediators of neurotoxicity. Neurotoxicology 13: 139-147.
49. Eberhard DA, Brown MD, VandenBerg SR, (1994) Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am J Pathol 145: 640-649.
50. Ohkawa H, Sohma H, Sakai R, Kuroki Y, Hashimoto E, et al. (2002) Ethanol-induced augmentation of annexin IV in cultured cells and the enhancement of cytotoxicity by overexpression of annexin IV by ethanol. Biochim Biophys Acta 1588: 217-225.
51. Matteo RG, Moravec CS, (2000) Immunolocalization of annexins IV, V and VI in the failing and non-failing human heart. Cardiovasc Res 45: 961-970.
52. Kahl CR, Means AR, (2003) Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 24: 719-736.
53. Berridge MJ, Lipp P, Bootman MD, (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1: 11-21.
54. Yano S, Tokumitsu H, Soderling TR, (1998) Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 396: 584-587.
55. Kondapaka SB, Singh SS, Dasmahapatra GP, Sausville EA, Roy KK, (2003) Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Mol Cancer Ther 2: 1093-1103.
56. Sampson HA, Leung DY, Burks AW, Lack G, Bahna SL, et al. (2011) A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol 127: 1309-1310 e1301.
57. Richardson PG, Wolf J, Jakubowiak A, Zonder J, Lonial S, et al. (2011) Perifosine plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase I/II trial. J Clin Oncol 29: 4243-4249.
58. Giannakakou P, Robey R, Fojo T, Blagosklonny MV, (2001) Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 20: 3806-3813.
59. Heliez C, Baricault L, Barboule N, Valette A, (2003) Paclitaxel increases p21 synthesis and accumulation of its AKT-phosphorylated form in the cytoplasm of cancer cells. Oncogene 22: 3260-3268.
60. Li W, Fan J, Banerjee D, Bertino JR, (1999) Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein. Mol Pharmacol 55: 1088-1093.
61. Shinwari Z, Manogaran PS, Alrokayan SA, Al-Hussein KA, Aboussekhra A, (2008) Vincristine and lomustine induce apoptosis and p21(WAF1) up-regulation in medulloblastoma and normal human epithelial and fibroblast cells. J Neurooncol 87: 123-132.
62. Zhai S, Senderowicz AM, Sausville EA, Figg WD, (2002) Flavopiridol, a novel cyclin-dependent kinase inhibitor, in clinical development. Ann Pharmacother 36: 905-911.
63. Liu G, Loraine AE, Shigeta R, Cline M, Cheng J, et al. (2003) NetAffx: Affymetrix probesets and annotations. Nucleic Acids Res 31: 82-86.